<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib34">
 <label>34</label>
 <element-citation publication-type="journal" id="sref34">
  <person-group person-group-type="author">
   <name>
    <surname>Brahemi</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Kona</surname>
    <given-names>F.R.</given-names>
   </name>
   <name>
    <surname>Fiasella</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Buac</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Soukupova</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Brancale</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Burger</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Westwell</surname>
    <given-names>A.D.</given-names>
   </name>
  </person-group>
  <article-title>Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer</article-title>
  <source>J.Â Med. Chem.</source>
  <volume>53</volume>
  <year>2010</year>
  <fpage>2757</fpage>
  <lpage>2765</lpage>
  <pub-id pub-id-type="pmid">20222671</pub-id>
 </element-citation>
</ref>
